Hepatitis B

Final days to save on AGA Postgraduate Course

April 10, 2018

Early bird deadline is April 18 – last chance to save $75.

Efficacy of Ledipasvir and Sofosbuvir Treatment of HCV Infection in Patients Coinfected With HBV

March 1, 2018

The combination of ledipasvir and sofosbuvir for 12 weeks produced a sustained virologic response in 100% of patients with HCV infection who were coinfected with HBV.

Efficacy of Ledipasvir and Sofosbuvir Treatment of HCV Infection in Patients Coinfected With HBV

March 1, 2018

The combination of ledipasvir and sofosbuvir for 12 weeks produced a sustained virologic response in 100% of patients with HCV infection who were coinfected with HBV.

Developing a New Combination Treatment for HBV Infection

Feb. 27, 2018

Findings show that NVR3–778 and interferon combination therapy can be superior to monotherapy against hepatitis B (HBV) infection. Read more on the AGA Journals Blog.

Attend the AGA Postgraduate Course for Practical, Take Home Information

Feb. 12, 2018

Join us on June 2-3 in Washington, D.C. This course is held in conjunction with Digestive Disease Week® (DDW) 2018.

Efficacy of NVR 3-778, Alone and In Combination With Pegylated Interferon, vs Entecavir In uPA/SCID Mice With Humanized Livers and HBV Infection

Feb. 1, 2018

CAM, a new drug class, can potently block the production of HBV replication products in a mouse model with HBV infected humanized liver.

2018 AGA Postgraduate Course Resources

Jan. 17, 2018

Pre-order resources from the course when you register.
Advertisement

Save the Date: 2018 AGA Postgraduate Course

Jan. 11, 2018

This year’s course will take place on June 2 and 3, 2018, in Washington, D.C.

Case Clinic 3: A 29-Year-Old Caucasian Man With a History of Injected Drug Use

Nov. 30, 2017

Clinicians are challenged to determine the optimal approach to treatment, which involves selecting an appropriate treatment regimen based on viral genotypes and subtypes and employing efficacy protocols.

Why the VA is So Successful Tackling HCV

Oct. 26, 2017

VA experts tell how they get high-risk patients engaged, nationally.

Hepatitis B Virus Activates Signal Transducer and Activator of Transcription 3 Supporting Hepatocyte Survival and Virus Replication

Oct. 22, 2017

HBV activates STAT3 signaling in hepatocytes to foster its own replication but also to prevent apoptosis of infected cells.

An Unusual Cause of Obscure Gastrointestinal Bleeding

Aug. 30, 2017

Why did bleeding persist in a man with a one-month history of intermittent tarry to bloody stool despite medical therapy?

Risk Factors of Prednisolone May Outweigh Benefit in Treatment of Severe Alcoholic Hepatitis (SAH)

Aug. 17, 2017

Gastroenterology researchers discuss their findings in video abstract.

Previously Cured HCV Patients Can Be Reinfected

Aug. 3, 2017

Prevention will require attention to high-risk behaviors.

Make an Impact on World Hepatitis Day

July 27, 2017

World Hepatitis Day, July 28, is an opportunity to join in on the fight to end viral hepatitis.

Looking at the Twin Epidemics of HCV

July 6, 2017

Younger cohorts at risk of HCV need more attention.

New WHO Report: More Work Needed to Diagnose, Treat Viral Hepatitis Worldwide

June 22, 2017

Just 20 percent of people with hepatitis C have been diagnosed, and only 7 percent have been treated.

Member Benefit Spotlight: GastroSlides

June 15, 2017

Free access to AGA's GastroSlides is now a member benefit.

Course for NPs and PAs Benefits All Experience Levels

June 14, 2017

Find out how AGA's popular course, Principles of GI for the NP and PA, benefits all those who attend, regardless of experience level or practice setting.

Liver & Biliary Sessions Scheduled at DDW® 2017

April 17, 2017

Council leadership hand-picked a preview of sessions for you to add to your DDW® itinerary.

A New Pathway for Transmitting HBV DNA?

March 7, 2017

Extracellular vesicles carry HBV DNA as cargo that can be transmitted to other hepatocytes, researchers report in CMGH. Read more on the AGA Journals Blog.

Incidence of Hepatocellular Carcinoma in All 50 United States, From 2000 Through 2012

March 1, 2017

In an analysis of the incidence of HCC in all 50 US states, we found the rate of increase in HCC to have slowed from 2010 through 2012.

2017 AGA Postgraduate Course Online Sessions

Jan. 4, 2017

Order the on-demand online sessions from the 2017 AGA Postgraduate Course: The Full Scope of GI Advances to learn key treatment advances that you can immediately implement in your practice. Reduced pricing is now available.

HBV-Associated Acute Liver Failure After Immunosuppression and Risk of Death

Jan. 2, 2017

Patients undergoing chemotherapy should be screened for HBV infection and given appropriate antiviral therapies to reduce preventable mortality.